Poloxamer-188 (P-188) is a generic, off-the-shelf pharmaceutical compound that has been approved by the FDA as an agent to decrease human blood viscosity prior to transfusions. A research team at the University of Chicago discovered that P-188 also has the unique ability to heal cell membranes: it can seal and repair holes in membranes which, if left untreated, typically lead to cell death. Once the membrane is stabilized, the cell can begin its natural self-healing process. During this healing process, the repaired cells excrete P-188, which is safely removed from the body through the kidneys.
The Maroon Biotech E-Team created a new class of drugs based on the molecular structure of P-188. These new co-polymers could be used to treat human cellular injuries resulting from central nervous system (CNS) injury, heart attack, and stroke.